FDA Drug Application (201806) for EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE by HETERO LABS UNIT III

Back to FDA Applications sponsored by HETERO LABS UNIT III

Application Number201806
Product Number001
FormTABLET; ORAL
Dosage200MG; 300MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active IngredientEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient EMTRICITABINE12
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by HETERO LABS UNIT III